Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MCBRIDE PLC Director's Dealing 2021

Sep 7, 2021

4743_dirs_2021-09-07_8f1e9751-99b9-4e12-a0ac-d0e3d94a1859.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 0234L

McBride PLC

07 September 2021

7 September 2021

Notification and public disclosure of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and their persons closely associated ("PCA").

McBride plc (the Company) was notified that on 7 September 2021, Elizabeth McMeikan purchased 13,030 ordinary shares of 10 pence each.

This announcement and the following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation.

1.

Details of the Persons Discharging Managerial Responsibilities ("PDMR")/Relevant Employees/Person Closely Associated ("PCA")

a)

Name

Elizabeth McMeikan

2.

Reason for the notification

b)

Position/Status

Independent Non-Executive Director

c)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

McBride plc

b)

LEI

213800HX7FMPA2CIEF02

4.

Details of the transaction(s)

Section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification Code

Ordinary shares of 10p each

GB0005746358

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
77.1053 pence 13,030

d)

Aggregated information

Aggregated volume

Price

£10,046.82 13,030

e)

Date of the transaction

7 September 2021

f)

Place of transaction

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGZGGLKNGGMZM